Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2025-12-26 @ 5:45 AM
Study NCT ID:
NCT00022360
Status:
COMPLETED
Last Update Posted:
2013-06-18
First Post:
2001-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Taurolidine in Treating Patients With Recurrent or Progressive Glioma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-05
Start Date Type:
None
Primary Completion Date:
2001-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2001-10
Completion Date Type:
ACTUAL
First Submit Date:
2001-08-10
First Submit QC Date:
None
Study First Post Date:
2004-03-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-17
Last Update Post Date:
2013-06-18
Last Update Post Date Type:
ESTIMATED